WCN26-2461 LONG-TERM OPIOID AND GABAPENTINOID RELATED HARMS AMONG ADULTS WITH CHRONIC KIDNEY DISEASE: A TIME-UPDATED, POPULATION-BASED COHORT STUDY

Read full text Summarise with VIRAT
Authors: Christopher Henry Grant, Shona J. Livingstone, Huan Wang, Karen N Barnett, Patrick Barry Mark, Lesley Colvin, Samira Bell
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Over half of patients with chronic kidney disease (CKD) live with chronic pain. Optimal management strategies are unclear, however, despite a limited evidence base, half of patients with CKD are treated with opioids and a fifth receive gabapentinoids each year. Long-term safety data relating to new opioid or gabapentinoid use, which accounts for prevalent use among adults with non-dialysis dependent CKD, are lacking. This study aimed to establish the risks of new long-term opioid or gabapentinoid use for chronic pain among adults with CKD.

Fields of Study & Subjects

Opioid Use Disorder Treatment Pain Management and Opioid Use Pharmaceutical Practices and Patient Outcomes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104706–104706
Publication date
25 March 2026
Language
EN